Evaluation of hydrophilic, hydrophobic and waxy matrix excipients for sustained release tablets of Venlafaxine hydrochloride

Drug Development and Industrial Pharmacy

Volumn 39, Issue 8, 2013, Pages 1197-1206

  Yadav, Kiran ^a   Yadav, Deepak ^b,c   Srivastava, Anand Kumar ^b  

^a KURUKSHETRA UNIVERSITY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

^c NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Cetyl alcohol; HPMC; Modelling; Sustained release; Venlafaxine

Indexed keywords

EXCIPIENT; HEXADECANOL; HYDROXYPROPYLMETHYLCELLULOSE; UNCLASSIFIED DRUG; VENFAX PR; VENLAFAXINE; VENLOR XR;

ARTICLE; COMPRESSION; CONTROLLED STUDY; DRUG RELEASE; DRUG SOLUBILITY; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; MATHEMATICAL MODEL; MELTING POINT; SUSTAINED RELEASE FORMULATION; TABLET;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CHEMISTRY, PHARMACEUTICAL; CYCLOHEXANOLS; DELAYED-ACTION PREPARATIONS; EXCIPIENTS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MODELS, THEORETICAL; SOLUBILITY; TABLETS;

EID: 84879938428     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2012.704381     Document Type: Article

References (28)

1. Sweetman SC, Blake PS. (1999). Martindle's: Te Extra Pharmacopoeia. London Pharmaceutical Press, London.
2. Aguiar MMGBd, Albuquerque RPd, Marinho DS, Braga BRS, Dornelas CB, Oliveira A, Sousa VPd, Torres SR, Alviano DS, Alviano CS, Cabral LM, Holandino C. (2010). Oral sustained release nystatin tablets for the treatment of oral candidiasis: formulation development and validation of UV spectrophotometric analytical methodology for content determination. Drug Dev Ind Pharm, 36:594-600.
3. Hamza Yel-S, Aburahma MH. (2010). Innovation of novel sustained release compression-coated tablets for lornoxicam: formulation and in vitro investigations. Drug Dev Ind Pharm, 36:337-349.
4. Pajander J, Korhonen O, Laamanen M, Ryynänen EL, Grimsey I, van Veen B et al. (2009). Efect of formulation parameters and drug-polymer interactions on drug release from starch acetate matrix tablets. J Pharm Sci, 98:3676-3690.
5. Quinten T, De Beer T, Almeida A, Vlassenbroeck J, Van Hoorebeke L, Remon JP et al. (2011). Development and evaluation of injection-molded sustained-release tablets containing ethylcellulose and polyethylene oxide. Drug Dev Ind Pharm, 37:149-159.
6. Roberts M, Vellucci D, Mostafa S, Miolane C, Marchaud D. (2011). Development and evaluation of sustained-release Compritol® 888 ATO matrix mini-tablets. Drug Dev Ind Pharm, 1-9.
7. Shah SN, Asghar S, Choudhry MA, Akash MS, ur Rehman N, Baksh S. (2009). Formulation and evaluation of natural gum-based sustained release matrix tablets of furbiprofen using response surface methodology. Drug Dev Ind Pharm, 35:1470-1478.
8. Tamilvanan S, Venkatesh Babu R, Nappinai A, Sivaramakrishnan G. (2011). In vitro and in vivo evaluation of hydrophilic and hydrophobic polymers-based nicorandil-loaded peroral tablet compared with its once-daily commercial sustained-release tablet. Drug Dev Ind Pharm, 37:436-445.
9. Costa P, Sousa Lobo JM. (2001). Modeling and comparison of dissolution profles. Eur J Pharm Sci, 13:123-133.
10. Higuchi T. (1963). Mechanism of sustained-action medication. Teoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci, 52:1145-1149.
11. Hixson AW, Crowell JH. (1931). Dependence of reaction velocity upon surface and agitation. Ind Eng Chem, 23:923-931.
12. Korsmeyer RW, Peppas, NA. (1981). Macromolecular and modeling aspects of swelling-controlled systems. In: Roseman TJ, Mansdorf, SZ (Ed.), Controlled Release Delivery Systems. Marcel Dekker, New York, pp. 77-90.
13. Alderman DA. (1984). A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms. Int J Pharm Tech Prod Mfr, 5:1-9.
14. Colombo P, Bettini R, Santi P, Peppas NA. (2000). Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms and optimal performance. Pharm Sci Technol Today, 3:198-204.
15. Kanjickal DG, Lopina ST. (2004). Modeling of drug release from polymeric delivery systems-a review. Crit Rev Ter Drug Carrier Syst, 21:345-386.
16. Levina M, Rajabi-Siahboomi AR. (2004). Te infuence of excipients on drug release from hydroxypropyl methylcellulose matrices. J Pharm Sci, 93:2746-2754.
17. Miller-Chou BA, Koenig JL. (2003). A review of polymer dissolution. Prog Polym Sci, 28:1223-1270.
18. Mohamed FA, Roberts M, Seton L, Ford JL, Levina M, Rajabi-Siahboomi AR. (2012). Te infuence of HPMC concentration on release of theophylline or hydrocortisone from extended release mini-tablets. Drug Dev Ind Pharm. April 27, 2012. (doi:10.3109/0 3639045.2012.681053).
19. Ranga Rao KV, Padmalatha Devi K. (1988). Swelling controlled-release systems: recent developments and applications. Int J Pharm, 48:1-13.
20. Siepmann J, Peppas NA. (2001). Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev, 48:139-157.
21. Viridén A, Wittgren B, Andersson T, Larsson A. (2009). Te efect of chemical heterogeneity of HPMC on polymer release from matrix tablets. Eur J Pharm Sci, 36:392-400.
22. Makhija SN, Vavia PR. (2002). Once daily sustained release tablets of venlafaxine, a novel antidepressant. Eur J Pharm Biopharm, 54:9-15.
23. Crowley MM, Schroeder B, Fredersdorf A, Obara S, Talarico M, Kucera S et al. (2004). Physicochemical properties and mechanism of drug release from ethyl cellulose matrix tablets prepared by direct compression and hot-melt extrusion. Int J Pharm, 269:509-522.
24. Katikaneni PR, Upadrashta SM, Neau SH, Mitra AK. (1995). Ethylcellulose matrix controlled release tablets of a water-soluble drug. Int J Pharm, 123:119-125.
25. El-Shanawany S. (1993). Sustained release of nitrofurantoin from inert wax matrixes. J Control Release, 26:11-19.
26. Hamdani J, Moës AJ, Amighi K. (2003). Physical and thermal characterisation of Precirol and Compritol as lipophilic glycerides used for the preparation of controlled-release matrix pellets. Int J Pharm, 260:47-57.
27. Lee BJ, Choe JS, Kim CK. (1998). Preparation and characterization of melatonin-loaded stearyl alcohol microspheres. J Microencapsul, 15:775-787.
28. Wu PC, Tsai MJ, Huang YB, Chang JS, Tsai YH. (2002). In vitro and in vivo evaluation of potassium chloride sustained release formulation prepared with saturated polyglycolyed glycerides matrices. Int J Pharm, 243:119-124.